Skip to main content
Rural Health Information Hub

Website Search Results for: mmwr

348 webpages matched your search. Here are matches 251 - 260:

251. QuickStats: Drug Overdose Death Rates Among Persons Aged ≥15 Years, by Age Group and Urban-Rural Status — National Vital Statistics System, United States, 2020 - Resources
Date: Nov 2022

Bar chart showing rural and urban overdose death rates by age group for those aged 15-24, 25-44, 45-64, and 65 and older.

...MMWR (Morbidity and Mortality Weekly Report), 71(47), 1503 11/2022 Centers for Disease Control and Prevention...

252. Sociodemographic Variation in Early Uptake of COVID-19 Vaccine and Parental Intent and Attitudes Toward Vaccination of Children Aged 6 Months–4 Years — United States, July 1–29, 2022 - Resources
Date: Nov 2022

Reports on COVID-19 vaccination and parental intent to vaccinate children 6 months to 4 years old. Includes data by place of residence for urban, suburban, and rural areas.

...MMWR (Morbidity and Mortality Weekly Report), 71(46), 1479-1484 11/2022 Centers for Disease Control...

253. Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 — National Immunization Survey-Child, United States, 2020–2022 - Resources
Date: Nov 2023

Examines vaccination coverage for selected vaccines and doses among children born in 2019-2020. Supplementary Table 1 includes data for metropolitan and nonmetro areas by year and vaccine for birth years 2016 through 2020.

...MMWR (Morbidity and Mortality Weekly Report), 72(44), 1190-1196 11/2023 Centers for Disease Control...

254. What's MAT Got to Do with It? Medication-Assisted Treatment for Opioid Use Disorder in Rural America - The Rural Monitor - Rural Monitor
Date: Mar 21, 2018

An important aspect of the opioid crisis is opioid use disorder. This in-depth story focuses on the science behind the disorder and the use of an evidence-based treatment: MAT, or medication-assisted treatment. - The Rural Monitor

...MMWR report provides a granular look at urban and rural opioid data. From 1999 to 2015, the study...

255. Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey–Teen, United States, 2022 - Resources
Date: Aug 2023

Reports on trends in vaccination coverage among U.S. adolescents for ages 13 through 17. Includes nonmetro data on vaccination by age 13 and by age 14 for each birth year for the following vaccines: Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis), MenACWY (quadrivalent meningococcal conjugate), and HPV (human papillomavirus).

...MMWR (Morbidity and Mortality Weekly Report), 72(34), 912-919 08/2023 Centers for Disease Control...

256. QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Urbanization Level and Age Group — National Health Interview Survey, United States, 2020–2022 - Resources
Date: Feb 2024

Bar chart showing the percentage of children and adolescents aged 5-17 with a diagnosis of attention-deficit/hyperactivity disorder in metropolitan and nonmetro areas, overall and for the age groups 5-11 and 12-17.

...MMWR (Morbidity and Mortality Weekly Report), 73(5), 116 02/2024 Centers for Disease Control and Prevention...

257. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program — Cherokee Nation, Oklahoma, 2015–2020 - Resources
Date: Jun 2023

Reports results for the first five years of the Cherokee Nation Health Services hepatitis C virus (HCV) elimination program, which includes universal HCV screening, primary HCV workforce expansion, and harm reduction services.

...MMWR (Morbidity and Mortality Weekly Report), 72(22), 597-600 06/2023 Centers for Disease Control...

258. National, State-Level, and County-Level Prevalence Estimates of Adults Aged ≥18 Years Self-Reporting a Lifetime Diagnosis of Depression — United States, 2020 - Resources
Date: Jun 2023

Looks at U.S. adults 18 years and older self-reporting a lifetime diagnosis of depression. Includes a map showing county-level information, as well as a separate file providing model-based age-standardized county-level prevalence estimates.

...MMWR (Morbidity and Mortality Weekly Report), 72(24), 644-650 06/2023 Centers for Disease Control...

259. Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024 - Resources
Date: Nov 2024

Reports on effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) associated hospitalization for Alaska Native infants in their first RSV season and against medically attended illness for children in their first and second seasons in Alaska's Yukon-Kuskokwim Delta. Includes data by community type for the hub town with regional hospital and outlying villages.

...MMWR (Morbidity and Mortality Weekly Report), 73(45), 1015-1021 11/2024 Centers for Disease Control...

260. Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 — National Immunization Survey-Child, United States, 2021–2023 - Resources
Date: Sep 2024

Reports on estimated coverage with recommended childhood vaccines among children by age 24 months. Data for metropolitan and nonmetro locations is available in Supplementary Table 2.

...MMWR (Morbidity and Mortality Weekly Report), 73(38), 844-853 09/2024 Centers for Disease Control...